Pyxis Oncology
PYXS
PYXS
31 hedge funds and large institutions have $26.5M invested in Pyxis Oncology in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
31
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.76M | |
| 2 | +$938K | |
| 3 | +$78.9K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$67K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$63.4K |
Top Sellers
| 1 | -$3.01M | |
| 2 | -$1.51M | |
| 3 | -$434K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$299K |
| 5 |
Millennium Management
New York
|
-$78.4K |